EYECON Unveils EYECON[VERSATIONS] Programming, Special Events Lineup for NYC Eyewear Design Week

Published on February 18, 2026
NEW YORK—EYECON, the three-day, design-led luxury eyewear event, has announced the 2026 edition of its EYECON[VERSATIONS] on-site programming and curated special events. EYECON will take place at The Glasshouse during NYC Eyewear Design Week on March 6–8, 2026. This year’s EYECON[VERSATIONS] lineup brings together influential voices from eyewear, retail, design and optometry to explore the ideas shaping the future of the luxury eyewear community, organizers said in an announcement. Select sessions will be recorded and later released on the EYECON[VERSATIONS] podcast, extending the dialogue beyond the show floor.
Continue reading on website
Other news

OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares

February 18, 2026
LONDON and NEW YORK—OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, has announced the pricing of an underwritten public offering of 10,815,000 ordinary shares at an offering price of $1.85 per ordinary share. The company said it granted the unde

Glaukos Reports Fourth Quarter and Full Year 2025 Financial Results

February 18, 2026
ALISO VIEJO, Calif.—Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, has announced its fourth quarter and full year 2025 financial results. Net sales in the fourth quarter of 2025 climbed to $143.1 million, a 36 percent increase (34 percent in constant curr